Dec. 8, 2025 — In November, The Lancet published an international expert consensus review, “Contemporary, non-invasive ...
Dec. 10, 2025 — The Singapore-MIT Alliance for Research and Technology (SMART), Massachusetts Institute of Technology’s ...
Nov. 25, 2025 — Remington Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance and announced ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Nov. 30, 2025 – Ascend Cardiovascular, a provider of purpose-built enterprise imaging for cardiology, and Konica Minolta ...
Dec. 3, 2025 — Atraverse Medical, a medical device company developing next-generation left-heart access technology, has ...
Dec. 3, 2025 — Recross Cardio Inc., a structural heart company developing next-generation membrane sealing technology ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Dec. 2, 2025 — At RSNA 2025, Siemens Healthineers announced Syngo.CT Coronary Cockpit1, a new software solution within ...
Dec. 2, 2025 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, has announced the ...
More than 1 million patients undergo a cardiac catheterization each year,1 but those numbers could decline as more ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Dec. 1, 2025 — Cleerly, a provider of AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025 ...
Nov. 30, 2025 — KA Imaging Technology has announced that its Reveal 35C detector with SpectralDR technology will be ...
Dec.1, 2025 – MannKind Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted the sNDA ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Nov. 24, 2025 — InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke ...
Nov. 19, 2025 — Promising results from a pivotal Phase 3 clinical trial of an investigational heart-attack drug were ...
Nov. 18, 2025 — RapidAI announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the ...
December 11, 2025
